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1. Introduction
Currently, ischemic cerebral vascular accident (ICVA; stroke) is an illness with a high incidence
and a high mortality rate [1,2]. In Brazil, depending on the state of the Brazilian Federation
and the period analyzed, cerebrovascular disease is the leading cause of mortality [3]. More‐
over, survivors present a continuous risk of developing serious complications [4]. Carotid
atherosclerotic disease is the cause of approximately 15 to 20% of cerebrovascular accidents [5].
Carotid stenosis is present in 7% of men and 5% of women aged 65 years or older [6]. In serious
cases (>70% stenosis), stenosis is an important cause of ICVA and transient ischemic attack
(TIA). The estimated risk of ipsilateral ICVA in 5 years is 4% in the population without carotid
stenosis; the risk increases to 18% in patients with asymptomatic stenosis above 75% and
reaches 27% in symptomatic patients with stenosis >75% [7]. Several authors have described
risk factors associated with carotid atherosclerosis, such as age, smoking, systemic arterial
hypertension (SAH), hypercholesterolemia, coronary artery disease, peripheral vascular
disease, and male gender [4,8,9].
2. Treatment of carotid stenosis
Treatment options for carotid stenosis include medication or surgery [10-12]. Clinical treat‐
ment includes antiplatelet agents and statins associated with the control of risk factors such as
arterial hypertension, dyslipidemia, hyperglycemia, diabetes, and smoking [13]. Relevant
studies comparing the outcomes of clinical treatment and surgery showed an important
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reduction in the risk of CVA among the patients selected for surgical treatment. In the NASCET
study, the risk of CVA was significantly reduced by surgery (9% in the surgical group versus
26% in the medication treatment) [10]. In another classical trial with asymptomatic patients,
surgical treatment was also associated with a better prognosis (4.8% versus 10.6% for medi‐
cation treatment) [14].
The two main effective treatment options for patients with serious carotid stenosis are carotid
endarterectomy (CEA) and carotid angioplasty with stent (CAS). CEA was the first surgical
option developed. It is indicated for symptomatic patients with carotid stenosis >60% and in
centers with surgical risk below 6%. In asymptomatic patients, a degree of stenosis >70% is
considered an indication for surgical treatment, but surgeons must notice morbi-mortality
lower than 3% [10,14-17].
The most recent surgical option is CAS, which consists of an approach to stenosis through a
natural route within the vessels. A flexible guide wire and catheter are inserted into the arterial
system through a peripheral venipuncture and are maneuvered to the stenosis site, where the
narrow portion is opened using the stent and balloon dilation.
CAS is considered less invasive than traditional surgery (CEA) and does not require an incision
on the lateral side of the cervical region [18]. CAS also has the advantages of being able to
maintain a steady flow of blood to the brain during CAS with a filter, generally using local
anesthesia, and allowing early hospital discharge [18]. Thus, the indications for CAS are the
same as those for CEA and also encompass other situations, such as comorbidities, occlusion
of the contralateral carotid artery, high carotid bifurcation, concomitant distally associated
stenosis, postradiotherapy stenosis, and restenosis after carotid endarterectomy [9,19,20].
The CREST trial compared CAS and CEA, examining complications, such as CVA, myocardial
infarction, or death during CAS and CEA, and CVA four years after these techniques were
applied. The authors observed similar rates of complications between CAS and CEA and
concluded that the techniques are equivalent in terms of short- and long-term clinical results,
but CAS carries a higher risk of ICVA and CEA carries a higher risk of heart attack during the
periprocedural period. This study also found that good results might be influenced by good
treatment and the expertise of the interventionists and surgeons [12].
Currently, CAS is considered a safe and effective technique for treating stenosis in the carotid
artery >70% in symptomatic patients, when assessed by noninvasive methods, and >50% when
assessed by catheter angiography, as indicated by the guidelines of the American Stroke
Association (ASA; Class I recommendation with evidence level B) [21].
The first angioplasty for carotid stenosis was performed by Mathis in 1979 in a patient with
fibromuscular dysplasia that caused symptomatic carotid stenosis [22]. The first angioplasty
for atherosclerotic lesions was reported in 1980 by Kerber et al. [23]. The first series of carotid
angioplasties was published in 1987 by Theron et al. and included 11 patients [24]. At the
beginning of the 1980s, publications regarding the use of balloon occlusion in the carotid artery
to reduce embolic complications began to appear [24-26].
The first balloon-expandable stent was used in a carotid artery in 1989; however, these early
stent models were prone to extrinsic compression and deformation. In this group of stents,
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adverse effects occurred in more than 10% of patients within the short 30-day follow-up
[27,28]. Subsequently, deformation was avoided using the self-expandable Wallstent® stent
[29] and later by self-expandable nitinol alloy stents. However, the risk of cerebral embolism
remained, although it was reduced compared with the risk associated with the first stents.
Restenosis, which occurred frequently after angioplasties without a stent, was reduced
drastically. Currently, all manufacturers of endovascular intervention materials produce
stents with rapid self-expanding technology compatible with the thin 0.014-inch guides
common to most cerebral protection systems [13]. Nonetheless, carotid stenosis treatment with
either CAS with cerebral protection or with CEA continues to carry an inherent risk of
embolism.
3. Is there a difference between materials used in carotid angioplasty?
As the CREST Trial showed, the risk of ICVA in CAS is a technical problem that remains
unsolved [12]. A heavily debated topic in the literature is the design of the metallic alloy used
to outline the empty spaces, which are called cells. Different types of frames for the metal
skeleton can promote plaque stabilization, depending on the size of the free area between the
metal brackets. Stents with a braided metallic mesh, which are dense throughout, can be more
effective at covering the plaque and reducing the risk of embolism [30]. These closed-cell stents
are characterized by small cells (areas enclosed by metal) joined together (Figure 1). Segmental
rings connected to each other by points that are welded together and large areas that are not
covered by metal are called open-cell stents [30]. Hybrid stents, which have a closed-cell design
in their central part and an open-cell design in their proximal and distal parts, can also be
found. These stents are rarely used in practice.
There are several examples of closed-cell stents, such as Wallstent® (Boston Scientific), Xact®
(Abbott), and NexStent® (Endotex). The Carotid Wallstent® is considered the prototype for
closed-cell design stents. Examples of stents with an open-cell design include Protégé® (Ev3),
Precise® (Cordis), Acculink® (Abbott), and Exponent® (Medtronic). The Carotid Wallstent®
model is manufactured with a stainless steel alloy and a closed-cell mesh, which may help to
prevent embolic complications. Because of its design, the Carotid Wallstent® (Boston Scien‐
tific) undergoes a shortening by approximately 30% [31], and caution must be used when
estimating its length. The Precise® (Cordis) stent is a nickel and titanium alloy (nitinol®)
mounted on rings, which promotes an open-cell aspect and offers great flexibility. The
Protégé® (Ev3) stent also uses nitinol and an open-cell design, and both conical and straight
versions are available. These last two stents cannot be collected after they begin to release;
therefore, they should only be opened when the implant site is certain. However, these stents
do not undergo shortening.
A study by Tadros et al. used photomicroscopy to analyze debris found in the filters after CAS
and showed that open-cell stents are associated with a larger mean particle size compared with
closed-cell stents [32].
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The results for angioplasty should be analyzed considering that there are ongoing major
evolutions in methods and materials. The results of angioplasties after the introduction of
stents and cerebral protection systems cannot be compared with the results of studies con‐
ducted before the development of these materials [13,32-37].
Although the initial purpose of carotid stenosis treatment is the prevention of cerebral
infarction, both CEA and CAS carry risks of causing infarcts [13]. The materials and techniques
have been modified to reduce the risk of embolic complications during CAS. Several authors
[32-38] have shown the rare relative incidence of cerebral embolism and death after carotid
angioplasty with or without cerebral protection.
Our experience with carotid angioplasty began in 1998 and 2000. At that time, cerebral
protection systems were not available in Brazil. During this period, 72 CAS were performed,
and the combination of neurological complications and death reached 5.5%. In the subsequent
period (2001 to 2007), 1215 CASs were performed with filters for cerebral protection, and our
occurrence of neurological complications and death fell to 1.8% [38].
Although some authors defend the use of CAS without cerebral protection, we emphasize that
symptomatic embolism is rare and that the use of safety devices, such as cerebral protection
systems, functions as a reserve parachute: Although they are rarely needed, no one wants to
jump without one (recommendation class IIa, level of evidence: C, [39]).
Currently, several devices are capable of providing cerebral protection during carotid stenosis
treatment, but the morbimortality results differ for each device. The forms of protection for
each device are also different. Nonetheless, other authors using various methods (most notably
Figure 1. Typical arrangement of the metal mesh of an open-cell stent (A) and a closed-cell stent (B). The area of a cell
in each type of stent is highlighted in red
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Doppler and MRI) have shown that an enormous load of emboli to the brain may not determine
symptoms. This phenomenon is called an asymptomatic embolism associated with CAS.
There are two types of cerebral protection systems: proximal and distal. The protection systems
with filters are distal, and the protection devices with balloons can be proximal or distal.
Proximal devices have the theoretical advantage of exerting protection during all phases of
intervention, except during the positioning of the guide catheter or the long sheath. The
proximal devices use temporary occlusion of the common carotid artery with a balloon, and
a second balloon occludes the external carotid artery, resulting in the stagnation or reversal of
the flow of the internal carotid artery (example: the PAES® Parodi antiembolism system). With
this type of device, protection is initiated before the stenosis is crossed with the guide wire,
which can reduce the risk of distal embolization. After the stent is implanted, the blood is
aspirated from the carotid bifurcation to remove any fragments, and later, the proximal
protection device is removed [40-42].
In contrast, with the distal devices, it is necessary to cross the stenosis with the microguide
and then to use the distal device on the lesion. Therefore, the distal systems consist of a device
(filter or balloon) with an integrated guide wire. This set-up allows the CAS to be performed
along the guide wire. With the distal protection, embolization can occur when the guide
catheter or sheath is positioned and during the passage of the guide wire through the stenosis
before the distal device enters the action.
Distal protection systems allow two different forms of approach. One form is the occlusion of
the distal cervical internal carotid artery by a balloon (example: PercuSurge®). With this type
of system, there is a complete interruption of the antegrade flow, which provides protection
for the particles that do not reach the brain. After the CAS, manual aspiration is performed,
the balloon is deflated, and the system is removed [43,44].
The other form of distal protection is through the use of a filter (examples: EPI®, Angio‐
guard®, Spider®). In this device, the filter (Figure 2) crosses the stenosis and is implant‐
ed in the distal  cervical portion of the internal carotid artery.  The stent and balloon are
introduced over the guide to perform the CAS. There are different types of filters, but the
aim of all of them is to retain particles, thereby preventing embolisms from reaching the
brain and maintaining continuous blood flow. At the end of CAS, the filter is closed and
removed from the patient  with the embolic  material  inside [13].  In terms of  design,  the
filters  can be concentric  (examples:  Emboshield® and Angioguard® Cordis)  or  eccentric
(examples:  Filterwire  EPI/EZ®  Boston  Scientific/Target  and  Spider®eV3).  In  concentric
filters, the metallic guide occupies the center of the structure. In eccentric systems, the guide
is outside the center of the protection device [45,46].
Thus, the two main types of cerebral protection devices used in CAS are filters that allow distal
flow during the CAS and systems for the temporary occlusion of the carotid artery (balloons)
that promote the inversion or paralysis of flow to the brain. Some authors defend filtering
devices, but others defend the balloons because they are believed to offer more complete
protection of the brain. Furthermore, the use of these cerebral protection systems is not
supported in some patients.
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Although all devices have a common goal of preventing the entry of particles into distal
circulation, the perfect protection system does not exist [42]. Among proximal protection
systems with balloons, arterial occlusion is the weakest point because patients might not
tolerate it. Moreover, the contrast of vessels during the CAS is difficult because of flow
stagnation, which makes positioning the stent difficult. Moreover, this system is more
laborious and complex to use than filters. Additionally, proximal protection systems are very
high profile and tend to lead to hemorrhaging complications at the puncture site. The device’s
advantages include its ability to initiate cerebral protection at an early stage and to avoid
embolization during the initial passage of the wire through the stenosis [13,42].
The distal embolic protection devices with a balloon have the disadvantage of preventing
antegrade flow, which renders some patients intolerant of this type of device. The balloon may
also cause vascular lesions (example: pseudoaneurysm), and the affixture of the balloon may
be lost during the CAS. Moreover, images cannot be easily obtained while the balloon is in use
and, technically, the balloon is not very maneuverable. An advantage of distal protection
devices is their ease of use compared with proximal occlusion balloons [13].
Among the disadvantages of distal embolic protection devices with filters is that they may not
capture all particles and their delivery and recovery systems may cause embolisms. Some
filters may attach to the stent because of bad handling. The advantages of filters include the
preservation of antegrade flow to the brain during all stages of the CAS and the ability to obtain
graphic images easily. Some systems allow the operator to select which guide wire to use to
cross the lesion, which allows the filter to remain in contact with the arterial wall and the guide
wire to be moved during the CAS without mobilizing the filter [13].
Figure 2. Examples of cerebral protection devices: eccentric design (A) in the EPI® filter and concentric design (B) in
the Emboshield® system
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An advantage of using filters is their ability to maintain constant flow to the brain during all
stages of the angioplasty, unlike protection balloons, which promote the temporary halt of
flow to the brain. Carotid filters are also easier to use than occlusive or reverse flow protection
balloons.
4. Cerebral embolism in the surgical treatment of carotid stenosis
Despite the advantages of cerebral protection systems, Mu฀ller-Hu฀lsbeck et al., in their 2005
study of ex vivo pig carotid arteries with four types of filters and one type of cerebral protection
balloon, found that particles were passed with all of the protection systems tested [47]. Piñero
et al. [48], using the transcranial Doppler technique, observed signs of embolism during several
phases of CAS, including the initial unprotected phase. Similarly, Schimidt et al. [49] divided
the carotid angioplasty into five phases from start to finish. This comparative study used one
type of filter (EPI®) and one type of occlusive system with balloons (MO.MA®) and found
that particles were passed in all phases of both systems.
The transcranial Doppler tool can help identify signs of embolism during an unprotected phase
(before using the filter) or during the passage of the filter, and it can identify embolisms when
the stent or balloon is applied or the filter is removed [50,51]. The transcranial Doppler can
provide information about the flow in the polygon vessels [52] and show changes in the cervical
segment after angioplasty [53]. However, the Doppler assessment has the disadvantage of
evaluating only one vessel, usually the middle cerebral artery or the distal cervical internal
carotid artery on the carotid stenosis side, leaving a vast territory of the brain uncovered during
the evaluation of embolic phenomena. No correlation can be observed between the quantity
of microemboli identified during ultrasound and new embolism outbreaks found during MRI
[54]. In contrast, MRI can evaluate the entire encephalon, which is particularly important
because embolic events may occur during the CAS or during the angiography preceding CAS
in other areas of the brain supplied by the carotid undergoing CAS [46,48].
According to several authors, the use of cerebral protection systems is an important factor in
reducing the risk of cerebral infarction during CAS [9,13,34,55]. However, although most
patients are asymptomatic after CAS, signs of embolism can be detected using the transcranial
Doppler technique and MRI [56] because of different factors, such as the existence of pores in
the protection systems that allow particles up to 100 microns pass, the manipulation of the
artery before the filter is opened, the filter not adapting to the artery wall, and crucially, a lack
of proper training in handling the systems [46,48,49,54,57-63].
5. Imaging evaluation of cerebral embolism
We consider MRI an excellent method for evaluating cerebral ischemia in its various presen‐
tations. An MRI study of various acute neurological presentations of an ischemic nature
includes several forms of ischemia presentation on the images [64].
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Diffusion (DWI) is the best MRI technique to differentiate ischemia from chronic infarction.
While the latter shows an increase in diffusion, the former classically restricts diffusion [65].
The identification of acute lesions in patients with multiple chronic lesions makes DWI a tool
of unquestionable value in current imaging practice.
Water in tissues has a randomized translational movement (“Brownian motion”) in its
molecules caused by thermodynamic energy and the viscosity of the medium. This type of
movement is related to CDA, and MRI uses DWI to evaluate it [66,67].
Diffusion imaging is sensitive to the microscopic movement of water protons. Water protons
undergo a change during the transverse magnetization phase in the presence of a magnetic
field gradient. Thus, areas with greater diffusion (faster movement) are subject to a high degree
of signal attenuation compared with areas with lower diffusion (slow/restricted movement),
which show lower signal attenuation. Animals subjected to occlusion of the middle cerebral
artery (MCA) showed signs of ischemia in diffusion within 45 minutes. These findings are
believed to reflect the restriction of water movement by the cellular membrane. MRI’s greater
sensitivity for detecting acute ischemia in diffusion is believed to be a result of the movement
of water within the cell, which restricts the movement of water protons (cytotoxic edema),
while the T2-weighted images show a signal change that results mainly from vasogenic edema.
It is estimated that cytotoxic edema begins very soon after ischemic abuse, while the vasogenic
edema begins to develop 6 hours after the ischemic incident.
Moseley et al. [65] argued that significant diffusion decrease (restriction or reduction) in
ischemia reflects the deviation of an environment with extracellular water protons with a faster
diffusion to a more restricted intracellular environment, in addition to the depletion of the
sodium-potassium pump in the cellular membrane because of infarction. The cytotoxic edema
is thus responsible for reducing diffusion during ischemia.
Nonetheless, the diffusion of ischemia areas can be reversed after early reperfusion and are
potentially reversible if they occur after CAS. It has also been shown that ischemic lesions in
diffusion might not leave changes that appear in later MRI scans after TIA frames.
The embolic complications identified in DWI occur more frequently than the apparent low
rate of clinical complications would suggest. An MRI may quantify the ischemic foci, making
it an important method for validating the advantages and complications of CAS.
To examine this issue more deeply, we conducted a prospective randomized study (patients
chosen randomly from the outpatient neuroradiology service of INCOR) in a case-control
setting [68]. We used angiographic exams and MRI studies that showed cerebral embolism
represented by the diffusion sequence (DWI) before and after surgical endovascular treatment
to quantify, locate, and measure new restriction foci in diffusion MRI and to correlate the new
DWI restriction foci with demographic aspects (gender, age, side of the carotid treated, and
symptoms), risk factors for cerebrovascular disease, aspects of the angioplasty technique used,
and the presence of previous infarcts in MRI.
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6. Methods
Our sample consisted of 40 patients presenting carotid stenosis of atherosclerotic origin. The
patients were referred for MRI exams with diffusion techniques before and after CAS. All of
the patients in this prospective study signed an informed consent form. The inclusion criteria
were as follows: patients with serious carotid stenosis (shown by Doppler, ATC, or digital
subtraction angiography [DSA]) who were referred for endovascular treatment for carotid
atheromatous disease according to the local institutional guidelines, who agreed to participate
in the research protocol, and who had MRI studies conducted with diffusion techniques at
most 24 hours before and up to 72 hours after the CAS with a protection filter.
Exclusion criteria were the following: intra-arterial thrombi observed in the angiography
before CAS; patients with disabling complications from previous cerebral infarcts; contrain‐
dications for the MRI scan, such as a cardiac pacemaker or claustrophobia, patients with
macroemboli in the DSA after CAS, clinical conditions compatible with ischemia after CAS,
angiographic exam showing stenosis <60%, MRI exams with movement artifacts, and imaging
studies with serious stenosis in the contralateral cervical carotid, vertebral arteries, or intra‐
cranial arteries.
Three patients out of 40 were excluded because they showed stenosis <60%, and one patient
was excluded for having exceeded the maximum time established for MRI after CAS because
of coronary angina and hemodynamic instability.
The MRI studies were performed using commercially available single high-field equipment
(1.5 T, LX Horizon®, General Electric Healthcare) with a skull coil (“birdcage transmit/receive
quadrature”).
The MRI scans before and after CAS followed the same sequencing protocol:
• Locator: 256x128 matrix, FOV 27 cm, 10 mm thickness, 5 mm spacing, number of acquisitions
(“nex”): 1
• DWI: 128X128 matrix, FOV 22 cm, 5 mm thickness, 0 mm spacing, TE minimum 72.8 ms, TR
9000 ms, “b-value” 0 and 1000, diffusion direction: “all”, number of acquisitions: 2
• Coefficient of apparent diffusion: map of “ADC”
• T2W, axial, 288x224 matrix, FOV 22 cm, 6 mm thickness, 0.6 mm spacing, TE 102 ms, TR
4750 ms, echo train length 23, bandwidth 31.25 and number of acquisitions: 2
• T1W, axial, 256x192 matrix, FOV 22 cm, 6 mm thickness, 0.6 mm spacing, TE 14 ms, TR 475
ms, bandwidth 15.63 and number of acquisitions: 2
• Fluid-attenuated inversion recovery (FLAIR): axial,  256x192 matrix, FOV 22 cm, 6 mm
thickness, 0.6 mm spacing, TE 96 ms, TR 10000 ms, TI 2.100 ms and number of acquisitions: 1
• T2W, coronal, 288x224 matrix, FOV 22 cm, 6 mm thickness, 0.6 mm spacing, TE 102 ms, TR
4750 ms, bandwidth 31.25 and number of acquisitions: 2
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New foci (NF) of ischemia were defined as the presence of a hypersignal (restriction) in
diffusion after CAS that was not present in the same sequence before CAS. These foci were
considered recent, additional infarcts compared with the first MRI.
The opposite of a recent infarction caused by DWI after CAS is an old infarction that is present
in the T2W sequencing of the MRI before CAS. Chronic cerebral infarction is the end result of
prolonged ischemia. Areas of hypersignal in the cerebral parenchyma in the T2 sequence with
areas corresponding to the variable signal in T1 (with the tendency to be isointense compared
with the fluid in T1 and T2) without restriction in DWI and with no enhancement after
paramagnetic contrast were considered old infarctions (“T2W infarction”). Other diseases that
may have a signal aspect similar to that of old infarctions (for example: porencephalic cysts,
arachnoid cysts, low-grade astrocytoma) were excluded from the count because of their
topographic characteristics, their appearance on the edge of the lesion, or their appearance on
the surrounding tissue or because they showed a signal that differed from that of the fluid in
the other sequences in the MRI study.
The MRI images were analyzed by the consensus of two experienced neuroradiologists using
the eFilm® software without access to the clinical data or angiography and CAS data. If there
were discrepancies between the two neuroradiologists’ findings, the studies were analyzed by
a third observer to reach a consensus.
The NF were correlated with age, gender, side of carotid artery treated, presence of previous
symptoms related to carotid stenosis, risk factors for atherosclerosis and ICVA (diabetes
mellitus, systemic arterial hypertension, hypercholesterolemia, ischemic coronary artery
disease, arrhythmia, ischemic peripheral vascular disease, transient ischemic attack [TIA], and
ischemic cerebrovascular accident [ICVA]), percentage of carotid stenosis, presence of ulcers
in the atheromatous plaque, previous infarction noted on the MRI, number of catheters used,
number of arteries on which angiographies were performed, contralateral carotid occlusion,
endovascular access technique used to reach the common carotid artery on the side of the
angioplasty, type of filter, type of stent, volume of contrast used in the CAS and angiography,
fluoroscopy time spent during the procedure, and the localization, number, and diameter of
these NF. These parameters were also correlated between patients with only one NF and those
with multiple NFs.
The localization (laterality) of the encephalic NF was defined as ipsilateral if it coincided with
the area supplied by the carotid artery undergoing angioplasty. The localization of the NF was
defined as contralateral if the cerebral area did not coincide with the side of the CAS, meaning
the area was nourished by the carotid artery contralateral to the angioplasty or the area located
on the posterior fossa. In cases when it was impossible to determine laterality, the patient was
excluded from the analysis, which occurred with two patients. Patients 16 and 27 showed
stenosis in the carotid artery (left) and contralateral occlusion (right), with NF identified in the
area supplied by the right carotid artery. Under this condition, the flow to the carotid area can
use the anastomotic Willis polygon or openings in other collateral pathways can be determined
(for example: flow through the vasa vasorum or retrograde flow through the ophthalmic
artery). Thus, with NF in the area of the occluded artery, it is not possible to say with certainty
whether the embolism originated directly in the CAS or migrated through the anastomosis of
areas that revascularized the cerebral territory of the occluded carotid artery. Because of the
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difficulty of relating the localization of the embolism precisely with the artery that underwent
angioplasty, we decided not to include these two cases in the analysis of laterality.
The diameter of each NF was noted using the maximum diameter of the lesion in the DWI
sequence through a metric analysis determined manually in the software (eFilm®). For
comparison, the NFs were divided into three groups of diameters (<5 mm, between 5 and 10
mm and >10 mm) according to the stratification method published by other authors [69,70].
The patients with carotid occlusion contralateral to the CAS were noted. To mark the occlusion
of the internal carotid artery, we used DSA or MRI. In the absence of DSA in the carotid artery,
we defined occlusion using MRI when there was no “flow-void” phenomenon and a high
intravascular signal in the FLAIR sequence, compatible with thrombus in sections focusing on
the internal intracranial carotid artery. Both imaging methods were accepted as sufficient for
proving that a vessel was occluded.
Areas with DWI restriction after CAS (ischemia indicators) were correlated with demographic
aspects, aspects of the angioplasty technique, stenosis characteristics, and the presence of
previous infarctions on MRI. The quantification of stenosis in the carotid bulb studied was
using the NASCET method [10] with DSA in all cases.
7. Angioplasty technique used
The patients were divided into two groups: “brief” angiography and “complete” angiography.
An angiographic exam before CAS is conventionally called a brief angiography when the exam
only includes an angiography of the carotid artery that is a candidate for treatment. A complete
angiography includes the study of other cervical arteries or the aortic arch.
Antiplatelet therapy was standardized, and all patients received 75 mg clopidogrel and 100
mg acetylsalicylic acid orally on a daily basis, beginning at least five days before the procedure.
In the preparation of the materials, all of the introducers, catheters, and sheaths were pre‐
washed with physiologic saline flow and subsequently packed in a sterile container with
physiologic serum and heparin before arterial puncture.
Under local anesthesia and light sedation from the anesthesiologist, arterial puncture was
performed and the valved introducer was deployed in the common femoral artery, which was
fixed to the skin with a wire suture for safety. If there was significant tortuosity of the iliac and
femoral vessels, long introducers were sufficient to help stabilize the catheter and the catheter
guide in the common carotid arteries.
A bolus injection of 10,000 units of heparin was administered intravenously after the valved
introducer was installed. An atropine solution was prepared before the angioplasty and stored
until the stent’s release. Intermittent verbal communication was maintained with the patient
during the procedure by the doctors performing the CAS, as in the eventual clinical tests.
In all cases, the angiography of the carotid artery undergoing CAS was initially performed
with a 5 Fr angiographic catheter to confirm the stenosis shown with other methods. At this
point in the procedure, angiographies of the cerebral vessels nourished by the carotid artery
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were performed, and they were repeated at the end of the CAS to observe any possible arterial
occlusion. In all cases, a noniconic contrast with low osmolarity was used.
In all cases (n=36), an 8 Fr-caliber guide catheter was introduced into the common femoral
artery inside the valved introducer, and the distal extremity was positioned in the common
carotid artery undergoing CAS a few centimeters below the atherosclerotic plaque.
The possible methods for positioning the catheter guide safely in the common carotid artery,
close to the bulb, were defined as access techniques. The endovascular techniques for accessing
the carotid artery to be treated included direct access (DA), an exchange with the guide wire
in the external carotid artery (ECA), exchange with the guide wire in the common carotid artery
(ECC), and triaxial access (TRI). For the direct access technique (DA), the catheter guide was
introduced into the common carotid artery by sliding it over a guide wire (0.035 inches) that
had previously been placed in the artery.
The technique involving exchange with the guide in the external carotid artery (EEC) was as
follows: the tip of the guide wire (0.035 inches) was positioned in the external carotid artery
using a diagnostic catheter with a 5-Fr caliber (figure 3). It remained safely in this position
without colliding with the atheromatous plaque, providing a means for the catheter guide to
advance over the guide until it reached the common carotid artery. The ECC technique was
defined as when the guide was positioned in the common carotid artery, rather than the
external carotid artery, with the help of a catheter guide contained within a diagnostic catheter.
At this point, the catheter was removed, and the catheter guide reached the common carotid
artery by going over the guide. The TRI technique involved using a guide catheter with a
diagnostic catheter inside (the designs and materials varied for each case) and a guide (0.035
inches) placed inside the diagnostic catheter. The catheter was free to attempt several maneu‐
vers before the catheter guide penetrated the carotid artery for the angioplasty.
After positioning the catheter guide in the common carotid artery, one of the closed filter
cerebral protection systems can be extended beyond the stenosis by positioning it a few
centimeters above the stenosis close to the base of the skull, preferably in a rectilinear segment
open in this topography. We also observed whether the filter was adjusted to the size of the
artery to avoid dislocating the filter system during the subsequent maneuvers.
“Rapid exchange” filter systems were used, which consisted of a 0.014-inch microguide with
a polyurethane membrane filter with 100 to 140 μm pores (100 μm in AngioGuard® filters
[Cordis], 110 μm in EPI FilterWire EPI/EZ® filters [Boston Scientific/Target], and 140 μm in
EmboShield® filters [Abbott]).
All of the patients were scheduled for the primary technique (without prior dilation of the
stenosis via a balloon) using a stent with an appropriate diameter (7 to 8 mm) for each case
and sufficient length to cover the bulb and the entire atherosclerotic plaque distally and
inferiorly (at least 1 cm).
Self-expandable stents (Carotid Wallstent®, Boston Scientific/Target; Precise®, Cordis; and
Protégé®, ev3) designed for carotid use in a 0.014-inch guide system were used. Only the
straight version of the Protégé® stent was used in our study.
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After the stent was released, 0.5 mg of atropine was administered intravenously. After
tachycardia was observed, a catheter balloon was inserted and inflated inside the stent. The
angioplasty balloon had the function of shaping the stent smoothly. The same balloon size was
used for all of the procedures: 6 mm in diameter and 20 mm in length (Gazele®, Boston Scietific/
Target and Amiia®, Cordis). In this study, after the balloon was deflated, an immediate-control
cervical angioplasty was conducted with a smooth manual injection of the contrast medium
to avoid disturbing the filter and possibly mobilizing any waste that it retained.
Once control via cervical DSA at the end of the CAS was considered satisfactory (residual
stenosis at a maximum of 30%), the filter was collected. Later, after the removal of the filter
and the last stage of CAS, carotid angiographies for intracranial vascularization were per‐
formed in anteroposterior (AP) and profile to show that the artery subjected to CAS remained
patent. Additionally, the intracranial vessels were thoroughly studied and compared with the
preangioplasty angiograms to detect any macroemboli. The catheter guide was removed at
the end of the CAS, leaving only the arterial introducer in the inguinal region. Heparin was
not antagonized. After the CAS, the cases were monitored in the intermediate intensive care
unit for 12 to 24 hours with attention to the patient’s neurological state and especially his/her
blood pressure.
All of the procedures were performed by an experienced neuroradiologist (with over 20 years
of specialty experience) with the help of one or two residents. No patient showed any neuro‐
logical or other symptoms after the CAS. The follow-up for clinical observations was the in-
hospital period of four days.
The data were analyzed using several methods and logistic regression analysis. All cases were
evaluated using SPSS (Version 15.0). A p-value <0.005 was considered statistically significant.
Figure 3. Patient number 2, 70 years old, male with diabetes, hypertension and coronary ischemia, displayed transient
ischemic attack. . DWI exam after CAS (not shown) did not reveal micrusemboli. Angiography showed stenosis of 70%
(A) in the left carotid artery with additional imaging (ulcer). EPI® open carotid filter (arrow) and Wallstent (7 x 40 mm)
self-expandable stent (B). Control angiography after CAS (C)
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8. Clinical and demographic data for patients before CAS
Of the 40 patients who began the study, 36 completed the protocol. Their ages varied from 54
to 87 years (average: 72.08 years).
n (%)
n of patients 36 (100.00)
Male 25 (69.44)
Female 11 (30.56)
Right carotid artery 15 (41.67)
Left carotid artery 21 (58.33)
Symptomatic patients 27 (75.00)
Asymptomatic patients 09 (25.00)
Average age/standard deviation (years) 72.08 (±8.30)
Table 1. Distribution of demographic data for the 36 patients
Risk factors n (%)
TIA 17 (47.22)
ICVA 11 (30.56)
TIA or ICVA 26 (72.22)
Arrhythmia 04 (11.11)
Ischemic coronary artery disease 09 (25.00)
Diabetes 12 (33.33)
Peripheral vascular disease 19 (52.70)
Hypercholesterolemia 12 (33.33)
Hypertension 32 (88.88)
TOTAL 116
Table 2. Distribution of risk factors (n=36 patients)
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9. Data from the procedures and technical considerations of digital
subtraction angiography and carotid angioplasty with a stent
Degree of stenosis1 – average (variation) 76.31% (60-99%)
Ulcerated plaques – n (%) 14 (38.89%)
Contralateral carotid occlusion – n (%) 7 (17.95%)
“Broad” examn (%) 24 (66.67%)
“Brief” examn (%) 12 (33.33%)
Filter – n (%): Angioguard® 4 (11.11%)
Emboshield® 7 (19.44%)
EPI® 25 (69.44%)
Stent – n (%): Precise® 9 (25.00%)
Protégé® 5 (13.89%)
Wallstent® 22 (61.11%)
Catheterization technique – n Direct access 12
Exchange in the external carotid artery 10
Exchange in the common carotid artery 11
Triaxial 08
Fluoroscopy time (minutes; average) 665; 22.93 min/CAS2
N of catheters used (n; average) 83; 2.31 cat/patient
Contrast volume (milliliters; average) 5480 ml; 182.67 ml/CAS3
Vessels submitted to DSA (n; average) 106; average 2.94
1 Percentage of stenosis evaluated by angiography
2 Regarding fluoroscopy time, only 29 procedures were recorded (n=29). In seven patients, there were technical
problems that prevented precise measurement.
3 For contrast volume, only 30 procedures were recorded (n=30). In six patients, there were technical problems that
prevented precise measurement.
Table 3. Technical aspects and characteristics of the angiographic exams (n=36)
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10. Imaging results
10.1. Aspects of MRI before the CAS
The preliminary MRI study before CAS showed six restriction foci in diffusion in four (11.11%)
patients (Table 4 and Figure 4). These foci were not recorded as NF after CAS.
n (%) patients
Infarctions in T2 23 (63.9)
Foci of restriction in DWI (1ª MR) 4 (11.1)
Table 4. MRI data before CAS (n = 36)
Among the restriction foci in DWI before CAS, five out of six (83.33%) were ipsilateral to the
carotid artery for CAS, and only one focus was not ipsilateral to the carotid that was treated
(cerebellum). All hypersignal foci in DWI before CAS occurred in patients with symptomatic
stenosis.
Figure 4. Patient number 7, male, 60 years old, underwent angioplasty of the left carotid artery. Restriction foci in
DWI in the MRI scan before CAS (A). Manifestation found in 11.11% of patients. No NF were observed after CAS (B)
11. Aspects of MRI after CAS
There were no new areas of cerebral infarction after CAS in the analysis of conventional MRI
sequences.
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A comparison between the MRI diffusion sequences acquired before and after angioplasty
showed 59 NF of restriction compatible with cerebral ischemia, which were distributed in 18/36
(50%) patients (Figures 5 and 6). The average NF in the 36 patients was 1.6 NF/patient (Table
5), and the diameter varied between 1 and 25 mm.
NF number 59 (18 patients)
NF size - n (%)
<5 mm 35 (59.33)
5 – 10 mm 19 (32.21)
>10 mm 05 (8.46)
Vascular distribution (NF1) - n (%)
Ipsilateral 44 (77.19)
Contralateral 13 (22.81)
pt – patient
1 Two patients were excluded from the analysis of laterality
Table 5. Characteristics of new foci (NF) of hypersignal in DWI after angioplasty of the carotid artery
Figure 5. Patient number 9, 59 years old, underwent right CAS. DWI before CAS (A) without images of restriction.
After CAS (B): ipsilateral NF (including primary motor rotation) and contralateral NF. Asymptomatic patient.
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 Figure 6. Patient 27, male, 73 years old with right carotid artery occlusion and stenosis of the left carotid artery esti‐
mated at 70% by DSA (not shown). Before CAS: T2 sequence (A) shows old infarction in the territory of the right MCA
and diffusion sequence (C) without recent ischemia foci. The patient underwent DSA of both common carotid arteries
and CAS of the left. In the MRI study, the T2 sequence was unchanged after CAS (B) and the DWI sequence showed NF
in the head of the caudate nucleus to the right (D)
Laterality of NF % of NF n of NF Average2 P
IP 77.19 44 2.75
CL 22.81 13 0.81 0.063
Total 100.00 57 3.56
CL – NF contralateral to the area for CAS; IP – NF ipsilateral to the area for CAS
1 Two patients were excluded from the analysis of laterality.
2 NF/patients
Wilcoxon test
Table 6. Number and average of NF by laterality (n=16 patients1)
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Presentation of NF per patient n of NF n of pt Average
(NF/pt)
SD p
Single NF (1 nf/ pt) 9 9 1.00 0.00
Multiple NF (≥2 nf/pt) 50 9 5.56 3.43 <0,001
TOTAL 59 18
pt – patient
Mann-Whitney U test
Table 7. Distribution of NF (single or multiple)
Laterality Number of patients % of patients
IP pure 5 14.71
CL pure 5 14.71
Intersection (IP+CL in the same patient) 6 17.65
IP pure + intersection (IP+CL in the same patient)=11 patients=32.35%
IP pure: patients with only ipsilateral NF; CL pure: patients with only contralateral NF
1 Two patients were excluded from the analysis of laterality.
No statistical test
Table 8. Distribution of NF based on laterality per patient (n=34 patients1)
Laterality by patient n of NF Average2 p
IP pure 14 NF 2.80
CL pure 5 NF 1.00 0.053
Bilateral 38 NF 6.33
IP pure: patients with only ipsilateral NF; CL pure: patients with only contralateral NF; Bilateral: patients with both
ipsilateral and contralateral NF
1 Two patients were excluded from the analysis of laterality.
2 NF per case
Kruskal-Wallis test
Table 9. Number and average of NF according to laterality per patient (n=34 patients1)
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NF after CAS Average age (years) SD p
Without NF 71.83 9.03
With NF 72.33 7.75 0.855
Mann-Whitney U test
Table 10. Average and standard deviation of age in the groups with and without NF in the DWI after CAS.
Factor NF pNo Yes
n % n %
AGE (years)
<75 8 44.4 7 38.9
≥75 10 55.6 11 61.1 0.855
TOTAL 18 100.0 18 100.0
GENDER
Male 15 83.3 10 55.6
Female 3 16.7 8 44.4 0.080
TOTAL 18 100.0 18 100.0
CAROTID ARTERY
Right 8 44.4 7 38.9
Left 10 55.6 11 61.1 0.735
TOTAL 18 100.0 18 100.0
Logistic regression analysis
Table 11. Distribution of age, gender, and side of the carotid artery treated based on the appearance of NF in the DWI
after CAS.
NF
pYes No
n factors SD2 n factors SD2
Risk factors1(n=116) 60 1.75 56 1.18
n of patients Average (NF/pt3) n patients Average (NF/pt3)
Patients (n=36) 18 3.33 18 3.11 0.743
1 Risk factors for atherosclerosis/ICVA
2 Standard deviation for risk factors
3 Patient
Mann-Whitney U test
Table 12. Correlation of all risk factors with NF after CAS
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Risk factors
NF
pNo Yes
N % n %
TIA 8 44.44 9 50.00 0.800
ICVA 4 22.22 7 38.89 0.612
ICVA or TIA 12 66.67 14 77.78 0.845
ARR 2 11.11 2 11.11 1.000
COL 8 44.44 4 22.22 0.164
COR 4 22.22 5 27.78 0.701
DM 5 27.78 7 38.89 0.481
PVD 10 55.56 9 50.00 0.738
HBP 15 83.33 17 94.44 0.311
TIA: transient ischemic attack; ICVA: ischemic cerebral vascular accident; TIA or ICVA: cases with at least one ischemic condition;
ARR: arrhythmia; COL: hypercholesterolemia; COR: ischemic coronary artery disease; DM: diabetes; PVD: peripheral vascular dis‐
ease; HBP: high blood pressure
Logistic regression analysis
Table 13. Distribution of risk factors in relation to the appearance of NF after CAS
NF
pNo Yes
Patients n of pt1 % pt n of pt % pt
Asymptomatic (n=9) 7 77.8% 2 22.2%
Symptomatic (n=27) 11 40.7% 16 59.26% 0.121
1 Patient
Chi-squared test
Table 14. Occurrence of NF based on the presence of symptoms before CAS
Clinical status of the patient before CAS n of NF % of NF p
Asymptomatic 11 18.6
Symptomatic 48 81.4 0.263
TOTAL 59 100.0
Mann-Whitney U test
Table 15. Correlation between the presence of carotid disease symptoms before the procedure and the number of NF
after CAS
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Infarct in T2
NF
pNo Yes
n pt1 %2 n pt %
Without 10 55.6 3 16.7
With 8 44.4 15 83.3 0.037
TOTAL 18 100.0 18 100.0
1 Patient
2 Percentage of patients in the group with NF (n=18)
Logistic regression analysis
Table 16. Distribution of NF according to the presence of previous cerebral infarct (in T2) in the first MRI
Infarct in T2 n of NF %1 n of pt2 Average3 SD4 p
Without 3 5.08 13 0.23 0.44
With 56 94.92 23 2.43 3.31 0.011
TOTAL 59 100.0
1 Percentage related to the complete NF group (n=59)
2 Number of patients with cerebral infarct images on the initial MRI
3 NF/patient
4 Standard deviation
Mann-Whitney U test
Table 17. Distribution of the number of NF (after CAS) based on the presence of previous cerebral infarcts in T2 in the
first MRI
Figure 7. Patient number 19, 81 years old with bilateral stenosis in the carotid arteries. A DSA was performed in the
aortic arch, common carotid arteries, left subclavian artery, and brachiocephalic trunk before the CAS of the left caro‐
tid artery. Diffusion study before the DSA and angioplasty (A). After DSA and CAS, an NF was identified in the DWI in
the left hemisphere of the cerebellum (B). A new MRI performed 40 days after the CAS (not as part of the study proto‐
col) showed the absence of lesions in the DWI (C) and in T2 (not shown).
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One patient (Number 19) showed one NF in the cerebellum after angioplasty of the left carotid
artery (Figure 7). Forty days later, the same patient was admitted for an angioplasty of the
right carotid artery. Another MRI was performed at this opportunity (not as part of the research
protocol), and it did not show diffusion lesions in the infarct area in T2 or in the enhancement,
which is common for subacute cerebral infarctions.
12. Aspects of angiography and angioplasty
NF N Average P
Yes 18 73.83
No 18 78.78 0.239
Mann-Whitney U test
Table 18. Average degree of stenosis in the groups with and without NF after CAS
NF
pNo Yes
N % N %
Ulcers 7 38.89 7 38.89 1.000
Logistic regression analysis
Table 19. Presence of ulcers and appearance of NF after CAS
NF
Occlusion of contralateral carotid artery
pYes No
N % n %
Yes 3 16.66 15 83.33
No 4 22.22 14 77.77 0.674
Chi-squared test
Table 20. Distribution of NF according to the presence of contralateral carotid occlusion.
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NF Total time (min) Average(min)
SD
(min) p
Without (n=14) 323 23.07 10.48
With (n=15) 342 22.80 8.59 0.880
min: minute
Mann-Whitney U test
Table 21. Correlation of fluoroscopy time with NF after CAS
NF Volume(ml)
Average
(ml)
SD
(ml) p
Without (n=16) 2910 181.88 73.50
With (n=14) 2570 183.57 54.01 0.918
ml: milliliter
Mann-Whitney U test
Table 22. Correlation of contrast volume used in the CAS and the appearance of NF after CAS
Patients n of catheters1 Average2 p
Without NF 43 2.39
With NF 40 2.22 0.462
1 Total number of catheters used in each group
2 Average catheter/patient
Mann-Whitney U test
Table 23. Number and average of catheters used in the CAS according to the presence of NF in the final MRI
Patients n of vessels undergoing DSA Average1 p
With NF 56 3.11
Without NF 50 2.78 0.628
1 Vessels subjected to angiography per patient
Mann-Whitney U test
Table 24. Number and average of vessels subjected to DSA according to the presence of NF after CAS
Carotid Artery Disease - From Bench to Bedside and Beyond172
Arteries submitted
to angiography
NF
pNo (n=18) Yes (n=18)
n % n %
RCCA 13 72.22 16 88.89 0.220
RSUB1 4 22.22 2 11.11 0.379
BAT 6 33.33 9 50.00 0.313
ARCH 4 22.22 5 27.78 0.701
LSUB2 8 44.44 10 55.56 0.506
LCCA 15 83.33 14 77.78 0.675
RCCA: right common carotid artery; LCCA: left common carotid artery; ARCH: aortic arch; RSUB: right subclavian artery;
LSUB: left subclavian artery; BAT: brachiocephalic arterial trunk
1 RSUB includes angiography of the ipsilateral vertebral artery
2 LSUB includes angiography of the ipsilateral vertebral artery
Logistic regression analysis
Table 25. Number and percentage of each vessel subjected to DSA and the appearance of NF after CAS
Type of exam
(n=36)
NF
pNo Yes
n of pt % of exams n of pt % of exams
“Brief” (n=12) 7 58.33 5 41.67
“Broad” (n=24) 11 45.83 13 54.17 0.480
pt: patients
Logistic regression analysis
Table 26. Type of angiographic exam used and the appearance of NF after CAS
Technique used to access
carotid
Catheterization techniques
pWithout NF With NF
n1 %2 n1 %2
DA 6 50.00 6 50.00 1.000
ECC 5 50.00 5 50.00 1.000
EEC 4 36.37 7 63.64 0.283
TRI 6 75.00 2 25.00 0.124
DA: direct access; ECC: exchange in the common carotid artery; EEC: exchange in the external carotid artery; TRI: triaxial
1 Number of times that each technique is used in the group with and without NF
2 Percentage of access technique
Logistic regression analysis
Table 27. Correlation of catheterization techniques with NF after CAS
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Brand of stent
NF
pNo Yes
n %1 n %1
Precise® 4 44.45 5 55.56
Protégé® 2 40.00 3 60.00
Wallstent® 12 54.55 10 45.45 0.493
1 Stent/brand
Chi-squared
Table 28. Correlation of types of stent with NF after CAS
Stent brand n of stents with NF IP NF IP Average1 p
Precise® 9 18 2.00
Protégé® 5 5 1.00 0.245
Wallstent® 20 21 1.05
IP: ipsilateral
1 NF IP/stent
NOTE: In this data analysis, CASs with NF outside the area where the stent was implanted were excluded.
Kruskal-Wallis test
Table 29. Correlation of stent brands with NF after CAS considering only the side where the stent was implanted
Stent design n of stent with NF IP NF IP Average2 p
Closed cell 20 21 1.05
Open cell 14 23 1.77 0.128
IP: ipsilateral
In this aggregation of the elements, CASs with NF outside the area where the stent was implanted were excluded
1 Two patients were excluded from the analysis of laterality.
2 NF IP/stent
Mann-Whitney U test
NOTE: Open-cell stent: Wallstent®; closed-cell stents: Precise® and Protégé®
Table 30. Correlation of stent designs with NF after CAS considering only the side where the stent was implanted
(n=34 patients1)
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Filter brand
NF
p
No Yes
n % n %
Angioguard® 2 50.00 2 50.00
Emboshield® 2 28.57 5 71.43 0.367
EPI® 14 56.00 11 44.00
Chi-squared test
NOTE: 100 µm pores in AngioGuard®, 110 µm in EPI FilterWire EZ®, and 140 µm in EmboShield®
In this series, there was not a case in which excess thrombus or atheroma plaque materials determined acute occlusion
of the filter during the CAS.
Table 31. Occurrence of NF based on filter brand (n=36)
Filter brand n of uses NF IP2 Average3 p
Angioguard® 4 9 2.250
Emboshield® 6 12 2.000
EPI® 24 23 0.958 0.582
1 Two patients were excluded from the analysis of laterality.
2 NF ipsilateral
3 NFIP/filter brand
Kruskal-Wallis test
NOTE: 100 µm pores in AngioGuard®, 110 µm in EPI FilterWire EZ®, and 140 µm in EmboShield®
Table 32. Distribution of NF ipsilateral to the use of the filter, considering the different models (n=34 filters1)
Filter design n of uses NF IP2 Average3 p
Eccentric 24 23 0.958
Concentric 10 21 2.100 0.515
1 Two patients were excluded from the analysis of laterality.
2 NF ipsilateral
3 NF IP/filter system protection design
NOTE: Eccentric, EPI®; Concentric, Angioguard® and Emboshield®
Mann-Whitney U test
Table 33. Distribution of NF ipsilateral to the use of the filters, considering filter design (n=34 filters1)
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In summary, our DWI MRI study after CAS found that 50.00% of patients showed NF of
restriction/ischemia in DWI after CAS. All of the NF were clinically silent (100%). These NF
were located in a cerebral area fed by the cerebral artery subjected to CAS in 77.19% of patients
and an area smaller than 10 mm in 91.53% of patients. The NF in cerebral areas not fed by the
cerebral artery undergoing angioplasty corresponded to 22.81% of NFs. The presence of
previous cerebral infarcts on the MRI influenced the appearance of NF (p=0.037).
13. Discussion
13.1. Aspects of MRI imaging before CAS
The MRI scan before CAS showed great variety in the changes in the 36 patients, with special
attention to ischemic aspects. We found four (11.1%) patients with hypersignal foci (a total of
six foci) in the DWI MRI before CAS. These foci are considered recent ischemia foci, and they
are not reported as NF involved with CAS, although most remained after treatment. This rate
is similar to that reported by Jaeger et al. [56] In a study involving 70 CAS, the authors
discovered hypersignal lesions in diffusion before CAS in 10 (14%) of the patients, with a total
of 24 foci [56]. Images of ischemia in DWI were detected in 10 (19%) patients before CAS by
Hammer et al. [61]. Hammer et al. [61] suggested that recent ischemia foci presented by some
patients on the initial MRI indicate the relevance of performing an MRI scan before CAS to
guarantee that any foci in the MRI after CAS are related to the procedure.
Piñero et al. [48] found lesions in the DWI ipsilateral to the carotid artery undergoing CAS in
11% of the patients. In our data, 88.33% of the lesions found in the DWI before the CAS were
ipsilateral to the carotid artery treated. This result supports the idea that these plaques are
constantly forming emboli that can be sent to the brain.
Our data showed that carotid atherosclerotic plaques are probable causes of hypersignal
lesions in DWI before CAS and can be considered causes of ischemia symptoms. This finding
is corroborated by the fact that most patients were symptomatic (75.0%). Most of the patients
(63.9%) showed old cerebral infarcts in the T2 sequence of the MRI before CAS. In our series,
a strong correlation between the rates of old infarcts and positive symptoms was found (75.0%).
13.2. Diffusion MRI study after CAS
According to Bates et al. [13], while the primary purpose of revascularizing the carotid artery
is preventing cerebral infarction, current treatments, both CAS and endarterectomy, carry a
risk of triggering brain infarction.
All interventional procedures performed in craniofacial vascular regions carry an inherent risk
of causing embolisms to the brain with different levels of severity. In these cases, the diffusion
MRI technique is the most efficient tool for detecting acute focal cerebral ischemia [46,71,72].
Angioplasty is certainly the interventional procedure in the craniofacial region that carries the
greatest risk of embolism. This risk is well documented in various studies and varies greatly
among the different groups that it effects [35,37,73].
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The institution wherein the present study was conducted published data pertaining to 1,037
carotid angioplasties with stent implantation and cerebral protection in 2006. The incidence of
disabling neurological complications and death was 2.2% [38]. Despite the low morbi-mortality
of the method, the real incidence of embolism is not known because the patients remained
asymptomatic.
We found restriction foci in the diffusion MRIs of 18 of the 36 (50%) patients in our series. These
NF in the DWI after CAS are additional to those in the first MRI, which implies that the
procedure or some aspect of it is related to the appearance of NF. The fact that all of the patients
in this series were asymptomatic after CAS and remained so during the intrahospital obser‐
vation period should also be taken into account.
The percentage of patients with NF in DWI in similar studies is quite variable: 9 to 78% (9%
[74]; 15.8% [71]; 17.3% [48]; 20.4% [75]; 29% [56]; 30% [36]; 40% [61]; 41.5% [73]; 42% [46]; 42.6%
[69]; 43% [59]; 49% [34]; 52% [35], 54% [58], 59.2% [76]; 9 and 78% [77]; 70% [70]).
The comparison of different studies is very difficult because even a small variation in the period
after the CAS during which DWI was conducted might affect the result. In the study by Rapp
et al. [77], a total of 23 patients underwent two MRI exams after the CAS. The first MRI scan
was performed immediately after the procedure (1 to 2 h) and the second exam was performed
48 h later. The results indicated only two (9%) cases with NF in the DWI immediately after the
procedure and 18 (78%) cases with NF 48 h later [77]. In a recent meta-analysis that included
studies that followed the evolution of CAS by DWI (1,363 CAS), NF were found in 37% of
patients [37].
The study that is most similar to ours is Kastrup et al. (2006); this study found microembolia
in 49% of patients with cerebral protection. Two years later, the authors updated their series
and published that NF occurred after CAS with a cerebral protection filter in 52% of patients
[35].
du Mesnil de Rochemont et al. [46] found NF in 42% of CAS and, similar to our study, found
no neurological deficit. In addition to this study, several others [35,37,48,61,69,73] have found
that most patients remained asymptomatic after CAS, despite the presence of NF. These
findings encouraged us to look for factors that lead to ischemic changes.
Jaeger et al. [56] demonstrated that smaller NF are less likely to become definitive lesions. His
study showed that of the 59 restriction foci in the diffusion after CAS, only 17 (29%) were
observed in the T2 sequence. They found that 17% of the lesions smaller than 5 mm in the DWI
were visible in T2; 36% of the lesions in DWI between 5 and 10 mm were observed in T2, and
100% of the larger lesions (larger than 10 mm) were apparent in T2 [56]. As in Tedesco et al.
[70], we considered the hypersignal images in T2 as already defined and permanent ischemia
foci, unlike the lesions in DWI, which may be reversible.
In a series of 59 CASs, Jaeger et al. [56] found that 75% of NF were smaller than 5 mm; in the
series by Piñero [48], the lesions were smaller than 5 mm in 57% of patients. However, in a
series of 22 CASs in Roh et al. [78], all of the NF were smaller than 10 mm. In our study, small
NF (<10 mm) corresponded to a large majority (91.53%) of the NF, while large NF (>10 mm)
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composed only 8.46% of the NF; this result shows that the eventual emboli caused by the
procedure are small in size.
According to several authors, some lesions in DWI after CAS also occur in vascular regions
independent from the CAS and are most likely related to the catheterization procedure
[35,37,61,73]. Our data showed that most (77.19%) of the NF occurred in the region of the
carotid artery that underwent angioplasty. However, a significant difference was not observed
between the side of the CAS and the contralateral side in relation to NF.
In the publication by Piñero et al. [48], 67.9% of the NF were in the vascular area compatible
with the CAS. However, Hammer et al. [61] found a similar number by studying 53 carotid
angioplasties: 60% of the NF were in an ipsilateral situation to CAS and 40% occurred in
contralateral topography.
By studying carotid angioplasty, Poppert et al. [58found NF in DWI in area of contralateral
carotid or vertebral artery in 9.7% of patients. Poppert et al. [58] stated that during catheteri‐
zation, to reach the right internal carotid artery, the materials must pass the aortic arch at the
origin of other cerebral arterial trunks, such as the common carotid artery and left subclavian
artery, in addition to the brachiocephalic trunk next to the right vertebral artery. Thus, material
from plaques along this route can cause emboli in various brain regions beyond the area
nourished by the carotid artery undergoing CAS [58].
Maleux et al. [73] described their surprise at finding that 35.3% of the NF (26.3% in contralateral
anterior circulation and 9% in the cerebellum) occurred in regions not nourished by the carotid
artery ipsilateral to the CAS. They considered the manipulation of the guide wire, catheter, or
guide catheter in the aortic arch as a possible cause of the lesions [73].
A meta-analysis with data collected from CAS studies between 2000 and 2007 found lesions
in diffusion in 14.5% of CAS outside the region treated, and NF were observed in 35% of the
procedures in the region of the carotid artery treated by CAS [37]. Thus, catheterization was
one of the main causes of the microemboli.
In our study, half of the patients with NF had a single lesion (single NF), and the other half
showed multiple foci (varying from 2 to 11 NF), which totaled 50 NF. Thus, patients with
multiple NF accounted for 84.75% of the NFs found in diffusion. Our study reproduced the
finding of Piñero et al. [48]. These studies found a single focus in DWI in 53.6% of patients,
and multiple foci were found in 46.4% of the patients in diffusion after CAS [48].
In our study, we found five patients who showed ipsilateral NF, five patients who showed
contralateral NF, and another six who showed ipsilateral and contralateral NF simultaneously.
Thus, the ipsilateral situation was the main localization of the NF occurrence in absolute terms,
but the most common presentation was associated to the contralateral NF than isolated. A
similar distribution of laterality was found in a retrospective study by Tedesco et al. [70] of 27
CAS. Similar numbers were also observed by Hammer et al. [61], who, in a series of CAS under
cerebral protection, found eight cases with only ipsilateral NF, seven cases with exclusively
contralateral NF, and six cases with a combination of ipsilateral and contralateral NF. Accord‐
ing to these authors, these events can be related to the doctor’s skill in catheterizing the aortic
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arch and the supra-aortic trunks and to the prevention of emboli formation beyond the
collateral circulation by the Willis polygon or other routes [61].
When patients with NF in an area other than the carotid artery for angioplasty are excluded
(i.e., emboli resulting from catheterization), our risk of cerebral embolism from angioplasty
alone is reduced from 50.00% (18 patients) to 32.35% (11 patients).
du Mesnil de Rochemont et al. [46] found an average of one NF per patient in the ipsilateral
area, while Jaeger et al. found that the average number of NF ipsilateral to the CAS was 2.6
per patient and that the average number of NF contralateral to the CAS was 1.2 per patient [56].
In our study, the average number of ipsilateral NF was 2.8 per patient, and the average number
of contralateral NF was 1.0 per patient.
The highest mean (6.33) NF per patient was for the presentation of ipsilateral and contralateral
NF simultaneously. This finding justifies the idea that the initial angiography or the catheter‐
ization technique and the CAS are involved in the high average number of bilateral NF.
Our average number of NF per patient, which was higher than that reported by most authors,
may reflect the fact that most (66.7%) of our cases underwent a broad diagnostic exam before
the angioplasty. Thus, the hypothesis can be applied that, because most of the cases had
bilateral NF, these NF were more likely related to the catheterization than to the angioplasty
itself.
Because of the risk of embolism during angiographic exams (diagnostic) and in interventional
procedures such as CAS, we believe that the exams should be performed by certified and
experienced neuroradiologists only. This statement is supported by other authors [71,79].
Moreover, modern noninvasive methods can be used with good reproducibility in some
centers, allowing a definition of the anatomy, degree of stenosis, and intracranial circulation,
which enables decisions about the CAS to be made without the use of a broad angiography
before the CAS.
Several other authors [8,48,56,58,71,80-82] studied risk factors for the occurrence of athero‐
sclerotic disease and ICVA, including diabetes, hypertension, coronary artery disease,
ischemic peripheral vascular disease, hypercholesterolemia, arrhythmia, previous ischemic
stroke, previous TIA, vasculitis, and hemorrhagic cerebrovascular accident. Most authors did
not find significant differences related to the appearance of hypersignal foci in DWI. Some
authors found some relevant factors, but those were not confirmed by other authors.
Clinical risk factors were not significant determinants of the formation of NF after CAS in our
study. The only risk factor statistically proven to be involved in the creation of lesions in DWI
after CAS was a radiological factor: old cerebral infarcts shown on MRI images, especially in
T2W.
Our study found a tendency toward a greater number of NF in older patients (≥75 years) and
those who underwent angioplasty of the left carotid artery. Hammer et al. [61] identified a
tendency for NF to be found in patients with advanced age (>75 years); however, as in our
study, they failed to prove it statistically (p=0.1).
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du Mesnil de Rochemont et al. [46] confirmed this trend by finding that age above 70 years old
was a predictor for the occurrence of foci in diffusion, and they wondered whether this finding
could be related to the fact that more elderly patients have more diffuse atherosclerosis
compared with younger patients. These authors did not find a significant correlation for factors
such as gender, degree of stenosis, type of stent, type of filter, and risk factors, such as
hypertension, diabetes, smoking, hypercholesterolemia, coronary heart disease, and periph‐
eral arterial occlusive disease [46].
Generally, our group without NF showed fewer risk factors (56 factors) than the group with
NF after CAS did (60 factors). While not significant, the difference shows a tendency that the
more comorbidities the patient has, the greater his or her risk of developing NF in a CAS. The
difference was also not significant for the clinical conditions of previous ischemic cerebrovas‐
cular accident and transient ischemia attack. Similarly, for the risk factor of cerebral ischemia,
which was associated with both TIA and ICVA, the difference was also not significant.
In our group (n=36), which was characterized by advanced age (average of 72 years), serious
stenosis (average narrowing of 76.31%) and symptoms of previous ischemic conditions in most
patients (72.22%), the subgroup of previously asymptomatic patients showed a lower risk of
NF: only 18.6% of the observed NF. Moreover, a large majority, 48/59 (81.4%) of the NF
occurred in symptomatic patients. Despite this tendency, there was not a significant difference.
Hammer et al. [61], in a series of 53 CAS, identified a tendency to find NF in symptomatic
patients, although no statistical proof was found.
According to Kastrup et al. [35], it is conceivable that the high prevalence of active plaques
with thrombotic activity in recently symptomatic patients may determine the high rate of NF
in this group. When our patients are regrouped into asymptomatic (9 patients) and sympto‐
matic (27 patients) groups to evaluate the interference of previous symptoms with the
occurrence of NF, the hypothesis is confirmed. The asymptomatic patients did not develop NF
in most (77.8%) of the CAS cases, while the symptomatic patients showed NF in most cases
(59.3%). Again, the analysis did not prove a significant difference (p=0.121), but it confirms the
tendency for symptomatic patients to be at greater risk in the procedure. Piñero et al. [48] also
showed an increased risk of embolism in angioplasty for symptomatic patients in their series
(19.8%) compared to asymptomatic patients (10%; p = 0.155). This ratio is approximately 2:1,
while ours was approximately 2.7:1.
We found a significant difference in the NF lesions in DWI after CAS in patients with previous
infarcts (based on the T2 sequence) compared with those without. Cerebral infarct was present
in 63.9% of patients in our entire series. It was observed that most (83.3%) of the patients with
NF after CAS showed cerebral infarcts on the MRI before the CAS. Nonetheless, the patients
who did not show cerebral infarcts on the MRI before the CAS mostly evolved (55.6%) without
NF in the DWI after CAS (p=0.037). Again, the average number of NF varies enormously in
relation to whether the patient had or not a previous infarct on T2 (initial MRI). The average
NF in the group with a previous cerebral infarct was 2.43 NF/patient, while the average in the
group without a previous infarct was only 0.23 NF/patient (p=0.011).
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This association makes it clear that a definitive ischemic lesion in imaging (in T2W) is a great
risk factor for developing microembolic complications during carotid angioplasty. Thus, the
patients who have infarcts caused by embolism or other factors are the same patients who
present NF after CAS. Additionally, the tendency for symptomatic patients (who do not
necessarily always present infarcts on MRI) to exhibit more NF after CAS indicates that the
main cause of microemboli during CAS may be the patients’ condition, including the plaque
composition, risk factors, and how the atherosclerosis presents in their bodies. It is possible
that the NF are signs of the underlying disease, and they may be exacerbated during CAS. Our
idea about the vulnerability of plaque is shared by Piñero at al. [71], who evaluated the
composition of the material found in the filters after CAS and stated that the atheromatous
plaque and the vessel wall are the main sources of microemboli during CAS.
Despite several publications on signs compatible with microemboli after CAS and CEA, no
consensus can be found among authors regarding the real clinical representation of NF.
According to some authors [62,69], the clinical value of NF after CAS is not adequately clear.
In our study, although 50% of patients showed foci compatible with ischemia in the diffusion
after angioplasty, none showed ischemic neurological syndrome. Some published series have
obtained a similar result, meaning most patients with NF after CAS were asymptomatic [46,54].
While the brain shows some tolerance for microemboli [83,84], the fact that subclinical deficits
promoted in the NF areas after CAS may cause long-term neurological deterioration cannot
be neglected. Long-term studies on cognitive function are needed.
The clinical impact of these clinically “silent” lesions in the brain that do not cause motor,
sensory, or linguistic deficits (i.e., in non-eloquent brain areas) was debated by Bendszus [63,
80]. According to these authors, there is evidence that the cumulative load of ischemic brain
injury can cause neuropsychological deficits or aggravate vascular dementia.
However,  the discrepancy between the clinical  safety of  CAS and the number of  NF of
ischemia is intriguing. It is known that there can be TIA abnormalities in DWI that undergo
regression  and  do  not  cause  lesions  that  remain  as  ischemic  scares  in  T2.  Despite  the
normalization of DWI after TIA, structural damage caused by late neuronal apoptosis may
be present, even in the absence of tissue necrosis [63]. For these authors, DWI shows the
entire picture of emboli during different procedures, and the ischemic conditions are only
the visible tip of the iceberg [63].
Studying the DWI sequence in patients with clinical conditions of TIA, Kidwell et al. showed
that in five of nine patients with ischemia foci in DWI after TIA, no evidence of infarcts was
found in follow-up imaging scans, indicating that almost half of the lesions from DWI in TIA
may be completely reversible on imaging [85]. Thus, we most likely overestimate the true
incidence of cerebral ischemic lesion after CAS when we base it only on DWI of MRI.
Although not part of research protocol, an MRI scan was conducted 40 days after CAS in a
patient who showed NF in the MRI after CAS. The third MRI scan did not show ischemic
lesions in the DWI or in T2. Thus, the NF indicated in the MRI after CAS proved evanescent
(like short-lived). This suggests that small lesions in the DWI that occur after CAS and are
clinically silent may not be definitive ischemic lesions.
Cerebral Protection in Carotid Angioplasty – Is There a Need? Advantages and Disadvantages of...
http://dx.doi.org/10.5772/57154
181
Similarly, a small study (seven patients) from Schlüter et al. [86] identified reversal on imaging
in 76% (5/21) of the NF after CAS at an average MRI follow-up four months later. A recent
study showed that 92.1% of the signs of microemboli disappeared and that 5.2% remained in
an MRI study three months after the CAS [72]. Thus, the NF after CAS are potentially reversible
on imaging and without neurological developments [60,75,86].
Some authors [69,87] correlated the neurological deficits after CAS with the diameter of the
foci of ischemia in the DWI. Small lesions were associated with good clinical evaluation. Small
NF (>5 mm) were reported as having the highest chance of not becoming definitive ischemic
lesions in later MRI scans compared with NF larger than 5 mm [75]. In addition to the size of
the foci in DWI, the topography may also determine whether the lesion will be clinically silent
or not [56,71].
For Piñero et al. [48], the position of the lesions in the diffusion was predominantly cortical
and subcortical in 67.9%.The study by Jaeger et al. showed that 95% of the NF had a cortical/
subcortical localization, mainly in the area of the ACA and MCA. Jaeger et al. considered this
distribution to be more compatible with standard cerebral embolism than with types of
cerebral ischemia [56].
Similar to Piñero et al. [48] and Jaeger et al. [56], the predominant pattern of the NF in our
study were lesions with small diameters and apparently random distribution. This finding is
compatible with the topography of the distal arteries, including the cortical and subcortical
vessels and perforating branches. There was also no predominance in border (“watershed”)
areas of vascularization.
Although we found NF in various areas, such as the motor cortex and basal ganglia, the
patients presented no clinical deficit during the hospitalization period. It may be that because
the NF had a small volume, they were less relevant for clinical lesions due to collateral
circulation, despite being in eloquent area. Nonetheless, improvement in cerebral perfusion
was shown after CAS in publications by Tavares and Caldas and may counterbalance clinical
damage resulting from microemboli that occur after CAS [68,88,89].
13.3. Aspects of angiography, angioplasty, and cerebral protection
In addition to maintaining a constant flow to the brain in all phases of CAS, cerebral protection
with a filter is likely to be used in all cases (unlike the occlusive balloon technique, which is
reserved for patients who are candidates for temporary carotid occlusion) [42]. Other limita‐
tions of techniques that use balloon for cerebral protection include severe tortuosity of the
cervical and thoracic arteries and increased diameter of the external carotid >6 mm [72]. These
were our reasons for choosing filters as a means of protection in our cases.
Angiographic factors and factors in the angioplasty, such as percentage of stenosis, presence
of ulceration in the plaque, and number of catheters used, did not show a statistically signifi‐
cant difference in our study with respect to the appearance of NF after CAS. In contrast to our
findings, Ohki et al., studying ex vivo angioplasty with stent, found that the greatest number
of particles during the procedure was associated with serious stenosis >90% [90]. Gauvrit et
al. [74], similar to our findings, did not find a significant difference between the degree of
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stenosis in groups of patients with and without NF after CAS. Schnaudigel et al. [37], in a meta-
analysis, considered that the degree of stenosis influenced the incidence of NF after CAS;
however, it was difficult to compare the articles because of great variation in the diagnostic
methods (DSA, CTA, MRA, and Doppler) and methodologies (NASCET, ECST or not men‐
tioned) used to grade the stenosis [37]. Roh et al. [78] found NF after CAS in eight of 22 (36%)
cases. Thus, similar to us, they did not find a significant difference in the presence of NF in
relation to the presence or absence of ulcers in the plaque. Among our patients, the percentages
with ulcers were identical in the groups with and without embolism in CAS.
We note that ulcers did not influence the result of embolism, although one of the steps,
overcoming the ulcerated stenosis by the still-closed closed filter, occurred without cerebral
protection. This fact may suggest the safety of filters in crossing stenotic lesions, even ana‐
tomically complex ones, such as ulcerated plaques. More studies are needed to prove this
hypothesis. Lacroix et al. [69], in a series of 61 CASs, analyzed technical conditions such as the
procedure duration and presence of ulcers in atheromatous plaque. They did not find a
correlation between these elements and the frequency of NF in DWI.
We did  not  find  a  significant  difference  between contralateral  occlusion  and the  occur‐
rence of NF after CAS. This finding confirms the clinical reasoning that patients with carotid
stenosis and contralateral carotid occlusion have an embolism risk similar to that of other
patients  during  CAS  treatment.  This  fact  contrasts  with  endarterectomy,  for  which  the
clinical results are materially negatively influenced by the presence of contralateral carotid
occlusion [10,91-93].
The fluoroscopy time used in CAS may reflect the technical difficulty of the procedure as
this time is equivalent to the set of short intervals in which X-ray was applied during the
maneuvers necessary for the catheters,  guides,  balloons,  stents,  and other materials [82].
Pinheiro et al. [48] used fluoroscopy for 21 min (average) per CAS, a result similar to our
series (22.93 min per CAS). As in our study, Tedesco et al. [70] did not find a correlation
between long fluoroscopy times or greater amounts of contrast and the appearance of NF
after CAS. Conversely, Rapp et al. [77] found an increase in NF after CAS depending on
the fluoroscopy time used. However, the fact that we did not find a significant difference
in the fluoroscopy time between the groups with and without embolism suggests that cases
in which the angioplasty is technically difficult may require longer times for the interven‐
tionist, but theoretically, the increased time does not increase in the risks of embolism. The
CASs in this study were always conducted by an individual with a considerable amount
of experience. The only way to exclude this bias would be to evaluate the learning curve
of a technician in training, which may explain the results of [77].
Although each contrast injection has an unknown theoretical risk of carrying emboligenic
particles, this was not proven in our series, but there was not a significant difference in volume
between the groups with and without NF. Nonetheless, we remember that, in medical services
such as ours with a neuroradiology practice, the cases of embolism are possibly not due to the
technique used because the contrast volume and the fluoroscopy time are similar for both
groups. Moreover, it is possible that the risk of embolism may be endogenous to patients at a
neuroradiology institution where the iatrogenic embolism factor is studied and controlled. The
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study by Kato et al. [94], as well as ours, did not find a significant difference in the groups with
and without NF regarding contrast volume, duration of the procedure, and the use of addi‐
tional catheters.
In our series, greater number of angiographies was found in the group that showed NF, and
the occurrence of NF varied based on the type of exam applied. Most of the exams defined as
broad were associated with emboli, and most of the brief exams did not show any NF after
CAS. However, there was no statistical confirmation.
Following the same trend, the average DSA per patient was greater in the patients with NF
(average 3.11) than among patients (average 2.78) without NF. Despite the theoretical risk of
increasing embolism with the diagnostic exam, the statistical analysis was not sufficient to
prove this hypothesis. Thus, the greater the number of vessels on which angiographies were
performed, the higher the occurrence of NF. The logical deduction is that conventional
angiography has the same responsibility for causing NF as angioplasty alone.
The catheter itself is a potential source of embolism, although complication rates are low [95],
and most complications are asymptomatic ischemic complications [61]. Bendszus et al. were
the first to publish diffusion MRI as a detection method for clinically silent emboli after cerebral
angiographies. They found 42 hypersignal foci in the DWI in 23 out of 100 (23%) patients after
DSA with manual injection of the contrast, all without neurological deficits [80].
Britt et al., in a short series, estimated an incidence of less than 9% of asymptomatic cerebral
infarcts in diffusion in patients undergoing cerebral angiography for diagnostic purposes [96].
Kato et al. [94], in a study of 50 patients, observed NF in the diffusion after DSA in 8 of the 41
(19.51%) patients. Chuah et al. [97] found NF after angiographies in 3 of 20 (15%) patients, all
of which were smaller than 10 mm and occurred at a rate of only one per patient.
Angiography of the aortic arch before CAS was associated with a high risk of microemboli,
according to a publication of 27 CASs by Tedesco et al. [70]. This study reports that the
aortography by catheter was avoided in cases where ulcers or stenosis were identified in the
aortic arch during the revision of exams conducted immediately before CAS. Some authors
have reduced the use of aortography by catheter. After the inclusion of MRI angiography in
the protocol by Rapp et al. [77], digital angiography by catheter was abolished in 81% of CASs.
In the detailed statistical analysis using logistic regression of our data, we did not find a
significant difference between DSA of the aortic arch (p = 0.701) and the appearance of NF in
diffusion after CAS. In addition to CAS and DSA, several other catheter techniques show risks
of cerebral embolism during the procedure. Rordorf et al. [98] found lesions in diffusion in 8
of 14 (57%) patients after embolization of unruptured cerebral aneurysms. In this series, the
majority, with the exception of one new focus, was ipsilateral to the treated aneurysm [98].
Cronqvist et al. [99] published a series of 21 patients suffering from cerebral arteriovenous
malformation who underwent 50 embolization procedures. In their study, NF were less
frequent (22% of procedures). Of the 35 NF found in DWI, 23 (66%) were of ischemic origin, 8
(23%) represented perinidal venous clots, and 4 (11%) were of uncertain origin [99].
Brain catheterization is not the only cause of brain embolism. In prospective studies, there was
an incidence of up to 15% for cerebral NF after cardiac catheterization [100]. Ischemia foci in
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DWI are found in a substantial number of carotid surgeries (endarterectomy), heart and
coronary surgeries, and interventions with cerebral angiographies [63,101,102]. Cardiac
bypass surgery may induce NF for cerebral ischemia in up to 45% of patients [103].
Willinsky et al. [82] point to mechanisms related to brain catheterization, such as throm‐
boembolism resulting from the withdrawal of the guide within the catheter. The withdrawal
causes the empty space of the catheter to fill with blood. This space is subjected to stagnation,
unnoticed by the inexperienced practitioner, and causes the formation of emboli [79]. Other
mechanisms cited are the dissection and fracture of plaques; the fragmentation of plaques with
catheters, guide catheters and guide wires; platelet activation; changes in clotting factors; and
the introduction of air bubbles [36,46].
Willinsky et al.  [82] published a five-year retrospective study of 2,899 cerebral angiogra‐
phies and found neurological complications in 39 (1.3%), 20 of which were transitory (0.7%),
five (0.2%) were reversed, and 14 (0.5%) were permanent. Neurological events in angiogra‐
phy  were  significantly  more  frequent  in  older  patients  (>55  years)  and  patients  with
concomitant cardiovascular disease and when the fluoroscopy was longer [82]. Kaufmann
et  al.  [95]  published the  widest  series  of  cerebral  angiographies  that  resulted in  clinical
complications by evaluating 19,827 consecutive patients in a 22-year retrospective study at
the Mayo Clinic. They found neurological complications in 2.63% of patients, permanent
infarcts in 0.14%, and deaths in 0.06% [95]. Hematoma at the puncture site was the most
common occurrence (4.2%). The independent factors identified as associated with neurolog‐
ical  complications  included  atherosclerotic  cerebrovascular  disease,  transient  ischemic
attacks, and subarachnoid hemorrhage [95].
Therefore, we assume that there is a theoretical risk of brain embolism, including possible
severe ischemic events, with all of the interventional procedures.
According to some authors, the diffusion MRI technique is the most efficient tool for detecting
acute focal brain ischemia [68,71,76].
Among the interventional procedures, carotid angioplasty achieved a significant reduction in
embolism with the introduction of protection systems, but emboli were not avoided com‐
pletely [35,37,46,68,73]. Good practice in neuroradiology procedures appears to be a mitigating
factor for embolic damage during carotid angioplasty procedures. Consistent with our idea,
Verzini et al. and Piñero et al. said that the interventionist’s experience is a factor for reducing
periprocedural complications [68,71,104]. For du Mesnil de Rochemont et al. [46], uninten‐
tional movement of the filter during the intervention is a potential cause of microemboli and
mainly occurs during the initial learning curve. This movement can largely be avoided with
improved interventional technique and new materials [46,68]. We believe that the learning
curve for CAS might be long and could exceed 200 cases.
Tedesco et al. [70] stated that their CAS program was modified to include the omission of the
aortic arch. This change began when MRI images provided sufficient anatomic detail and
initiated anticoagulation before the passage of guides and catheters in the ascending and
transverse aorta [70]. Thus, these authors state that aortography should be reserved for patients
for whom the MRI before CAS does not provide anatomic details to guide the catheter. In
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contrast, these same authors affirm that more complex and challenging aortic arches (described
as Type II and Type III) were not identified as high risk for embolization [70]. Most authors
describe rates of non-symptomatic NF in DWI in the area contralateral to CAS that are similar
to brain angiography rates.
The initial catheterization of CAS cannot be excluded because the procedures cannot be
separated. Although the catheterization occurs alone for diagnostic purposes [80], angiogra‐
phy is a mandatory initial stage for all angioplasties [36]. Bendszus et al. [105] subsequently
published that the use of heparin and air filters materially reduced ischemic events in brain
catheterization.
Most studies on the relationship between NF in DWI and CAS only mention the material used;
few describe a single access technique for the common carotid artery, usually direct access. In
all cases, we used a standardized form for the highest-caliber (8 Fr) guide catheter, believing
that the good stabilization of the system achieved by this material facilitates the manipulation
of materials (filter, stent, balloons).
In our experience, direct access without exchanges is preferable only in technically simple cases
with favorable anatomy. According to our review, our study is the only one that comparatively
analyzes the catheterization access technique with the guide catheter in the carotid artery
undergoing angioplasty. The risk for each technique to be involved with embolism was 50.00%,
50.00%, 63.64%, and 25.00%, respectively, for direct access, exchange in the external carotid
artery, exchange in the common carotid artery, and triaxial. Thus, the triaxial technique
showed a tendency for greater safety, possibly by having a more gradual progression of size
(from the guide wire to the guide catheter) and causing less aggravation of the aortic arch and
supra-aortic trunks. We can add that the triaxial technique should be used as a first attempt
when technically possible.
Because the triaxial form of access showed a small number of NF, although without statistical
significance, it is possible to predict that replacing the set (a short-valved introducer and guide
catheter) with a long sheath (110 cm), which is currently available, in a single product that is
also used triaxially (introducer, sheath, and guide) may reduce the index of embolic compli‐
cations. More comparative studies of compatible techniques (guide, catheter, sheath) and other
techniques are needed to prove this trend.
Although the filter is the central focus of discussion in most articles cited here for preventing
embolization during CAS, the stent is the material used to effectively treat plaque to prevent
embolic ischemic conditions in the long run. Our data do not show important significant
differences between the brands of stent tested and the brands of protection filters used, as in
Kastrup et al. [35] and Palombo et al. [75]. However, it is possible to identify a tendency for a
smaller number of NF with a closed-cell stent (Wallstent®) compared with the open-cell stents.
The Protégé® stent showed a reasonable resolve for the appearance of NF ipsilateral to CAS,
but the small number of times this material was used precludes reliable statements about this
relationship.
Schillinger et al. [30], studying the impact of open-cell versus closed-cell stents, reviewed data
from 10 European centers totaling 1,684 patients and did not identify a significant difference
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regarding neurological complications and death up to 30 days after CAS. Additionally, du
Mesnil de Rochemont et al. [46] found a tendency for a greater number of ischemic lesions
with the use of segmented nitinol stents (open cells) compared to Wallstent®. They suggested
that open-cell stents are used in more technically complex cases with marked vascular
tortuosity. In our study, we obtained the same result, but the types of stents were used without
differentiation regarding tortuosity. A prospective study by Sahin at al. analyzing patients
with closed-cell and open-cell stents showed that open-cell stents were less associated with
clinical events of brain ischemia [106]. Moreover, Hart et al. [45], studying 701 CASs, stated
that closed-cell stents and eccentric filters had lower rates of TIA/ICVA/death combination 30
days after the procedure in symptomatic patients and patients with echolucent plaques in
ultrasound. Our results and from other authors led to the theory that these stent and filter
designs may be intrinsically more effective at preventing brain embolism from fractured
plaque or other thrombogenic material.
The retrospective analysis of 3,179 consecutive CASs by Bosiers et al. [107] showed a significant
difference with a greater rate of neurological complications (symptomatic or not) with open-
cell stents. Using DWI specifically to study NF after CAS, the recent meta-analysis from
Schnaudigel et al. [37] shows that the incidence of NF after CAS was significantly greater in
open-cell stents than in closed-cell stents. Thus, our study is in agreement with those of other
authors [32,37] and supports the idea that closed-cell stents are sufficient to cover plaque and
prevent the embolization of large plaque particles post-CAS through the struts of the stent.
Several studies with separated groups with and without cerebral protection support the
effectiveness of protection systems [34,35,37]. Kastrup et al. [33] found a combined frequency
of CVA and death after 30 days of 1.8% for the group with protection and 5.5% for the group
without protection (p<0.001). Additionally, a lower incidence of serious neurological compli‐
cations was found when a filter was used (2.2%) than without a filter (5.5%) [38]. By studying
groups with and without protection and the relationship with NF formation, Kastrup et al.
found emboli in 49% of patients with cerebral protection and 67% of patients without protec‐
tion [34]. Two years later, this group updated their data and published the occurrence of NF
after CAS without a filter in 68% of patients and 52% of patients with a filter [35].
As expected, the meta-analysis by Schnaudigel et al. [37] found a lower index of foci ipsilateral
to the CAS in DWI in patients with the use of cerebral protection systems (33%) than in patients
without the use of protection (45%). The same authors cited no change in the risk of NF
occurrence in the contralateral area with or without cerebral protection (respectively, 14% and
13%; p=0.6) [37]. In our study, all cases were performed with a protection filter. The use of a
control group without a filter would be considered unethical according to our research group.
However, different types of filters were compared, and the technique used to place the guide
catheter was analyzed.
In addition to innovation of materials, proper training is needed for each type of filter.
Attention to the correct apposition of the filter device should be a mandatory stage in the CAS
[108], as it requires experience in executing the procedure because of the natural tortuosity of
carotids. Positioning can be hampered by vascular tortuosity, which is sometimes excessive.
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The choice of filter is also important because, if it has a smaller diameter than the vessel, blood
and particles pass between the filter and the artery wall [46,104,109].
Two articles from Müller-Hulsbeck et al. [47,57] using an animal model of the carotid artery
showed that miniscule particles of debris smaller than 100 μm can pass the pores of the filters
[57]. Additionally, the filters can damage the vessel walls [47], which may subsequently result
in the displacement of fragments and thrombi due to accidental movement of the filtering
device. Other authors claim that we cannot exclude the possibility that when the filters are
closed and removed, the collection system may swing the tool and loosen some of the captured
particles, freeing them in the vessel lumen [46,68].
It is possible that because the stent and balloon use a microguide for the devices, in the case
of the EPI/EZ® and Angioguard® filters used in this study, they may mobilize the filter and
release free particles. The Emboshield® device does not carry this theoretical risk because it
stays no fixed to the guide while it is in action. However, in our study, the Emboshield® device
has an average appearance of NF similar to the other concentric device, Angioguard®, and
both have a higher average than the eccentric device EPI®. This result reflects the need for
training with each device because the only way of preventing the displacement of materials is
the correct use of the devices.
In 2000, Coggia et al. [110] published the passage of particles in all stages of CAS in an ex vivo
study. Most of the particles were smaller than 60 μm, and the pores of the commercially
available filters were approximately 100 μm. The passage of these particles through the
protection devices and entrapment in capillaries or cerebral arteries is possible [110]. Angelini
et al. [50] showed through electronic microscopy that 83.7% of filters have particles adhered
to them and, on average, the filters contained 33.7 particles (24 to 46). In that study, the average
diameter of the fragments captured in the filters was 289.5 μm (1.08 to 5043.5 μm). The main
particles found by this group were soft acellular material, lipid-laden macrophages, and
cholesterol clefts. Less frequently, they found calcium particles and platelet aggregates. All of
these materials are typically identified in atherosclerotic plaques, whether they are compli‐
cated or not. When a protective balloon was used, similar materials were found [50].
In 2009, Piñero et al. [111] published a structural analysis of the material contained in filters
after angioplasties and stated that atherosclerotic plaques and vessel walls are the main sources
of microemboli during CAS [71,111]. However, a study on the action of cerebral protection
devices found that 88% of particles were retained in the filters in an ex vivo simulation of CAS
[112]. Piñero et al. [48,71,111] considered filter diameter to be very important but not the only
factor in the formation of NF. They claimed that bad positioning of the filter on the carotid
wall due to tortuosity, displacement of the filter while handling the materials, and high profile
crossover are technical difficulties that await future studies and improvements in materials.
Rough handling can promote the formation of emboli during the positioning and removal of
the filter.
Some authors explain that the size of debris removed from the filters differs from the real size
at the moment of embolization and that most of the small emboli may be the result of the
fragmentation of particles trying to pass through the grid of the filter [113]. Thus, continuous
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flow predisposes the fragmentation of content retained in the filter. Physician experience and
speed are necessary to reduce the time of the procedure and avoid this fragmentation and
potential emboli between the pores [68].
The filters that were used in the protocol of this study had mesh with pores from 100 to 140
μm, reducing the migration of cholesterol crystals and clots, platelet aggregations, and
macrofragments of atheromatous plaques through filtering. The diameter of the filter pores
used was smaller than the particles described by Theron et al. [114] and Ohki et al. [90] and
than most of the particles described by Angelini et al. [50].
Our series showed an average of 1.6 NF per patient, a number well below the average of 33
particles found adhered to filters in the study by Angelini et al. [50]. It is possible that filters
provide real protection, given the disparity between these numbers. Nonetheless, the action
of each individual’s thrombolysis system cannot be excluded as also drastically, or at least
partially, reducing the permanence of emboli at its distal point.
The disparity between the low number of ischemic events after CAS [33,38] and the relatively
high frequency of multiple small restriction foci in diffusion after CAS [35,69,70,73] that are
compatible with embolism suggests that filters mainly act by retaining large particles that
could evolve into clinical conditions of ischemia, rather than by grasping small particles. In
our series, the eccentric filter EPI® had embolism in diffusion in 44% of cases, suggesting
apparently superior protection compared to other models. The Angioguard® filter contained
emboli in 50% of cases, while the Emboshield® device showed the highest rate of emboli
(71.43%) in the group. Our data establish a strong tendency for superior protection measured
in the eccentric filter (0.958 NF ipsilateral) compared to the concentric designs (2.100 NF
ipsilateral). A study from Tedesco et al. [70] found a high rate of NF (70% of patients). These
authors used a combination of the concentric filter and the open-cell stent, which may have
contributed to the high rate of emboli. While there may be unequal protection between these
filters, the difference shown in this series is not statistically significant. Our data cannot
completely indicate greater protection of the eccentric model compared to the concentric
model. Furthermore, poor distribution among types of filters with very small groups (Angio‐
guard®, n=4) was observed. Thus, we avoid speculative comparison regarding the safety of
each device.
A retrospective study of 3,160 CAS published Iyer et al. [115] found that the type of protection
(nine different systems, including concentric and eccentric filters and proximal and distal
occlusion balloons) had no influence on the clinical result. However, these authors did not
study the brain using MRI after CAS.
For Piñero et al. [48,111], the difficulty of correctly positioning the filter on the wall of tortuous
vessels, the displacement of material during the release, the creation of emboli by the relatively
high-profile crossover and low flexibility, the loss of accumulated particles during the removal
of the filter, and the diameter of the filter’s pores appear to be very important to the appearance
of ischemia related to embolization. This finding should lead to future studies that help to
perfect protection systems [48,111].
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In 2006, du Mesnil de Rochemont et al. [46] found three (6%) occlusions of filters by debris or
clots in a series of 50 CASs. In a series of 162 CASs, Piñero et al. found filter occlusion in four
(2.5%) patients during the procedure [48]. It is predicted that these cases will become significant
infarcts due to the large size of the particles because it was sufficient to obstruct the filter pores
up to total occlusion of the flow. Piñero et al. [48] assume that, without the use of a filter in
these cases, the morbidity of their series would increase from 4 to 6.5%.
There was no case of filter occlusion by debris or thrombi in our series. Vasospasms related to
the filtering devices were short-lived and without hemodynamic impairment. Other compli‐
cations related to the filters were not found in this series. Filter occlusion leading to a stopped
flow is a rare occurrence. It was more observed with the use of the first generation of EPI®
filters, where the diameters of the pores were only 80 μm [46,116].
While the first step in CAS, which includes catheterization, the positioning of the guide catheter
and the passage of the filter over the stenosis, occurs without protection, the phases with the
greatest number of emboli released from plaque are the implantation of the stent and the
angioplasty by balloon. An overload of the filter protection system is the angioplasty by
balloon. Piñero at al. [111] showed that the more balloon dilations are applied to CAS, the
greater the load of emboli found in the filters. Therefore, physician experience is necessary to
use the balloon as delicately as possible.
Unfortunately, the other technique currently used in the treatment of carotid stenosis – CEA
– also has ischemic complications [59] and more brain emboli than CAS [37,83]. Another
common complication in CEA is lesions to the cranial nerves and cardiac infarction [117,118].
Comparative studies between CEA and CAS found a greater number of NF after CAS than
after CEA. However, the lesions in the DWI after CAS are significantly smaller than after
the endarterectomy. Analyzing the NF in the DWI after CAS and endarterectomy, Roh et
al.  [78] reasoned that the lesions in diffusion after CAS are generally asymptomatic and
that the lesions in DWI associated with symptoms are more frequent in CEA [37,78].  In
recent years, the materials used in CAS have been improved to reduce complications. DWI
can  be  used  as  a  tool  in  this  evolving  analysis  of  materials  and  also  in  the  technical
improvement of neurointervention.
Our study shows some limitations. Data collection of a control group without the use of
cerebral protection to prove the device’s effectiveness is incorrect based on our ethical views
of the procedure, but it is a limitation of the study. However, other published studies that
conducted CAS with and without protection systems clearly show a smaller number of NF
[35,37] and lower risk of ischemic events [33,38] after CAS in the groups where the devices
were used.
The formation of emboli can be impeded by antiplatelet and anticoagulant medications [76],
but this is not the focus of our research shown here. In neuroradiology procedures, the
prevalence of resistance to aspirin varied from 2 to 21%, and resistance to clopidogrel varied
from 43 to 52% [119-121]. This result is extremely important because atheromatous plaques
and superimposed thrombi are the main source of microemboli during CAS. A recent study
from Song et al. [76] using the VerifyNow system showed that the frequency of resistance to
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clopidogrel was significantly higher in patients with foci of microemboli in DWI after CAS
than in patients without foci of microemboli in MRI after CAS. In their series, all the patients
who showed clinical ischemic events had resistance to antiplatelets [76].
A randomized prospective study evaluated platelet activation after coronary stents in pigs and
showed that the closed-cell stent produced less intimal prolapse and thus a smoother stent-
vessel wall interface than the stent with open-cells and that platelet activation was greater
during the 30 days following implantation of an open-cell versus a closed-cell stent [122].
Our study concentrates on the designs of stents and filters, but other particularities of con‐
structing the materials can interfere in the safety of CAS, such as the type of filtering element.
A study considered that perforated membrane filters have greater resistance to cerebral blood
flow [123], but it did not evaluate whether there was greater capture of emboli. Our study also
had a relatively short follow-up time. We only used the period when the patients were
hospitalized, generally three to four days. We consider that this peri-procedure period is
sufficient to evaluate the late appearance of NF because the disappearance of NF is described
in some cases [60,68,75].
14. Conclusions
The use of protection systems aims to avoid massive embolism, which occasionally happens.
However, a perfect cerebral protection system is not commercially available. While cerebral
protection with filters is effective, it is necessary to develop new protection devices that are
more effective and can be occlusive systems with a lower profile and greater ease of use. Both
techniques, angioplasty with stent (with filter or flow occlusion systems) and endarterectomy,
are involved in cases of intracranial embolism per treatment.
New restriction foci (NF) in diffusion were present in half of the patients after CAS with
cerebral protection and were most frequently located in the ipsilateral area (77.19%), suggest‐
ing that the filters did not prevent all microemboli. New restriction foci in DWI after CAS were
located in regions (22.81%) different than in the angioplasty and were associated with
diagnostic catheterization. Therefore, long neurointerventionist medical training should be
required before CASs are performed.
The NF in DWI after CAS were mostly small in diameter (<10 mm in 91.53%) and were always
clinically silent (100%) in our study.
The presence of cerebral infarcts in the T2 sequence in the initial MRI was the only factor that
significantly predisposed the appearance of new restriction foci in DWI after CAS. Thus, the
risk of microemboli was directly related to intrinsic factors of the patient. Other demographic
factors and aspects related to the angioplasty technique were not statistically significant to the
occurrence of NF in our study. There was a tendency for other factors, such as the triaxial access
technique, asymptomatic patients, and an eccentric filter, to be involved in the appearance of
a smaller number of NF after CAS.
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The appearance of microemboli attributed to catheterization and not angioplasty with stent
shows that proper training for medical specialists in cervical and cerebral circulation (neuro‐
interventionists) can be key to reducing risks for patients. General specialists in vessels
(vascular surgeons) and coronary circulation (cardiologists) generally do not have specific
training for cervicocerebral circulation; most of their training focuses on the aorta and coronary
arteries, respectively. We therefore recommend that angiographies to diagnose cervical and
cerebral circulation and carotid angioplasty be conducted by interventional neuroradiologists
to reduce the risk of emboli.
To maintain cerebral flow during the endovascular carotid treatment, CAS with filter is the
first choice in cases of serious stenosis. The use of occlusive systems is promising but requires
more technical development to reduce the risks associated current systems.
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